Annual Operating Profit
-$15.35 M
+$12.30 M+44.49%
December 31, 2023
Summary
- As of February 8, 2025, ALRN annual operating income is -$15.35 million, with the most recent change of +$12.30 million (+44.49%) on December 31, 2023.
- During the last 3 years, ALRN annual operating profit has risen by +$5.15 million (+25.12%).
- ALRN annual operating profit is now -19.06% below its all-time high of -$12.89 million, reached on December 31, 2015.
Performance
ALRN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$6.07 M
+$2.97 M+32.84%
September 30, 2024
Summary
- As of February 8, 2025, ALRN quarterly operating income is -$6.07 million, with the most recent change of +$2.97 million (+32.84%) on September 30, 2024.
- Over the past year, ALRN quarterly operating profit has dropped by -$4.09 million (-207.08%).
- ALRN quarterly operating profit is now -207.08% below its all-time high of -$1.98 million, reached on September 30, 2023.
Performance
ALRN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$29.62 M
-$4.09 M-16.04%
September 30, 2024
Summary
- As of February 8, 2025, ALRN TTM operating income is -$29.62 million, with the most recent change of -$4.09 million (-16.04%) on September 30, 2024.
- Over the past year, ALRN TTM operating profit has dropped by -$16.87 million (-132.31%).
- ALRN TTM operating profit is now -651.89% below its all-time high of -$3.94 million, reached on March 31, 2016.
Performance
ALRN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ALRN Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +44.5% | -207.1% | -132.3% |
3 y3 years | +25.1% | -29.1% | -7.1% |
5 y5 years | +51.9% | -29.1% | -7.1% |
ALRN Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +44.5% | -207.1% | +32.8% | -132.3% | +1.5% |
5 y | 5-year | at high | +48.8% | -207.1% | +32.8% | -132.3% | +1.5% |
alltime | all time | -19.1% | +51.9% | -207.1% | +37.1% | -651.9% | +7.3% |
Aileron Therapeutics Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$6.07 M(-32.8%) | -$29.62 M(+16.0%) |
Jun 2024 | - | -$9.04 M(+25.5%) | -$25.52 M(+37.5%) |
Mar 2024 | - | -$7.21 M(-1.3%) | -$18.56 M(+21.0%) |
Dec 2023 | -$15.35 M(-44.5%) | -$7.30 M(+269.3%) | -$15.35 M(+20.4%) |
Sep 2023 | - | -$1.98 M(-5.0%) | -$12.75 M(-26.1%) |
Jun 2023 | - | -$2.08 M(-47.9%) | -$17.25 M(-25.7%) |
Mar 2023 | - | -$3.99 M(-15.2%) | -$23.21 M(-16.0%) |
Dec 2022 | -$27.65 M(+3.9%) | -$4.70 M(-27.4%) | -$27.65 M(-7.1%) |
Sep 2022 | - | -$6.48 M(-19.4%) | -$29.76 M(-1.0%) |
Jun 2022 | - | -$8.04 M(-4.5%) | -$30.07 M(+7.2%) |
Mar 2022 | - | -$8.42 M(+23.5%) | -$28.04 M(+5.4%) |
Dec 2021 | -$26.61 M(+29.8%) | -$6.82 M(+0.4%) | -$26.61 M(+10.9%) |
Sep 2021 | - | -$6.79 M(+13.0%) | -$23.98 M(+7.9%) |
Jun 2021 | - | -$6.01 M(-14.0%) | -$22.22 M(+7.8%) |
Mar 2021 | - | -$6.99 M(+66.7%) | -$20.61 M(+0.6%) |
Dec 2020 | -$20.50 M | -$4.19 M(-16.6%) | -$20.50 M(-13.3%) |
Sep 2020 | - | -$5.03 M(+14.3%) | -$23.65 M(-10.9%) |
Jun 2020 | - | -$4.40 M(-36.0%) | -$26.54 M(-10.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2020 | - | -$6.88 M(-6.4%) | -$29.52 M(-1.5%) |
Dec 2019 | -$29.96 M(-6.1%) | -$7.35 M(-7.2%) | -$29.96 M(+1.2%) |
Sep 2019 | - | -$7.92 M(+7.3%) | -$29.59 M(+1.4%) |
Jun 2019 | - | -$7.38 M(+0.9%) | -$29.17 M(-7.2%) |
Mar 2019 | - | -$7.31 M(+4.7%) | -$31.45 M(-1.4%) |
Dec 2018 | -$31.90 M(+38.7%) | -$6.98 M(-6.9%) | -$31.90 M(-0.2%) |
Sep 2018 | - | -$7.50 M(-22.4%) | -$31.96 M(+3.5%) |
Jun 2018 | - | -$9.66 M(+24.4%) | -$30.89 M(+18.0%) |
Mar 2018 | - | -$7.76 M(+10.3%) | -$26.18 M(+13.8%) |
Dec 2017 | -$23.01 M(+26.6%) | -$7.04 M(+9.6%) | -$23.01 M(+12.7%) |
Sep 2017 | - | -$6.43 M(+29.8%) | -$20.41 M(+12.0%) |
Jun 2017 | - | -$4.95 M(+7.9%) | -$18.22 M(-3.2%) |
Mar 2017 | - | -$4.59 M(+3.2%) | -$18.82 M(+3.6%) |
Dec 2016 | -$18.17 M(+40.9%) | -$4.45 M(+5.1%) | -$18.17 M(+32.4%) |
Sep 2016 | - | -$4.23 M(-23.7%) | -$13.72 M(+44.6%) |
Jun 2016 | - | -$5.55 M(+40.9%) | -$9.49 M(+140.9%) |
Mar 2016 | - | -$3.94 M | -$3.94 M |
Dec 2015 | -$12.89 M | - | - |
FAQ
- What is Aileron Therapeutics annual operating income?
- What is the all time high annual operating profit for Aileron Therapeutics?
- What is Aileron Therapeutics annual operating profit year-on-year change?
- What is Aileron Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Aileron Therapeutics?
- What is Aileron Therapeutics quarterly operating profit year-on-year change?
- What is Aileron Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Aileron Therapeutics?
- What is Aileron Therapeutics TTM operating profit year-on-year change?
What is Aileron Therapeutics annual operating income?
The current annual operating profit of ALRN is -$15.35 M
What is the all time high annual operating profit for Aileron Therapeutics?
Aileron Therapeutics all-time high annual operating income is -$12.89 M
What is Aileron Therapeutics annual operating profit year-on-year change?
Over the past year, ALRN annual operating income has changed by +$12.30 M (+44.49%)
What is Aileron Therapeutics quarterly operating income?
The current quarterly operating profit of ALRN is -$6.07 M
What is the all time high quarterly operating profit for Aileron Therapeutics?
Aileron Therapeutics all-time high quarterly operating income is -$1.98 M
What is Aileron Therapeutics quarterly operating profit year-on-year change?
Over the past year, ALRN quarterly operating income has changed by -$4.09 M (-207.08%)
What is Aileron Therapeutics TTM operating income?
The current TTM operating profit of ALRN is -$29.62 M
What is the all time high TTM operating profit for Aileron Therapeutics?
Aileron Therapeutics all-time high TTM operating income is -$3.94 M
What is Aileron Therapeutics TTM operating profit year-on-year change?
Over the past year, ALRN TTM operating income has changed by -$16.87 M (-132.31%)